💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$133.4B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 2/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | $2.32B | $2.36 | 10.80% |
| XRAY | DENTSPLY SIRONA Inc. | $2.26B | $11.34 | 0.44% |
| ETNB | 89bio, Inc. | $2.20B | $14.84 | 0.00% |
| VERA | Vera Therapeutics, Inc. | $2.16B | $33.75 | 1.26% |
| OCUL | Ocular Therapeutix, Inc. | $2.11B | $12.14 | 0.04% |
| SRPT | Sarepta Therapeutics, Inc. | $2.09B | $21.32 | 1.79% |
| GPCR | Structure Therapeutics Inc. | $2.06B | $35.81 | 4.65% |
| JANX | Janux Therapeutics, Inc. | $2.05B | $34.09 | 1.73% |
| VCEL | Vericel Corporation | $2.04B | $40.25 | 0.30% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.03B | $35.29 | 0.76% |
| OGN | Organon & Co. | $2.00B | $7.71 | 0.39% |
| OLMA | Olema Pharmaceuticals, Inc. | $1.95B | $28.36 | 0.85% |
| SION | Sionna Therapeutics, Inc. | $1.94B | $43.57 | 0.50% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.91B | $84.85 | 0.58% |
| QDEL | QuidelOrtho Corporation | $1.86B | $27.35 | 0.55% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.86B | $4.63 | 4.99% |
| MAZE | Maze Therapeutics, Inc. | $1.82B | $37.75 | 0.66% |
| SYRE | Spyre Therapeutics, Inc. | $1.81B | $30.00 | 0.84% |
| CLDX | Celldex Therapeutics, Inc. | $1.80B | $27.02 | 0.86% |
| STOK | Stoke Therapeutics, Inc. | $1.77B | $30.91 | 0.96% |
| CURLF | Curaleaf Holdings, Inc. | $1.72B | $2.28 | 0.09% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.72B | $19.82 | 0.25% |
| AGIO | Agios Pharmaceuticals, Inc. | $1.70B | $29.20 | 0.55% |
| PAHC | Phibro Animal Health Corporation | $1.70B | $41.88 | 3.12% |
| TRVI | Trevi Therapeutics, Inc. | $1.69B | $13.19 | 0.75% |
| OMCL | Omnicell, Inc. | $1.69B | $36.51 | 0.41% |
| IMNM | Immunome, Inc. | $1.69B | $18.42 | 1.13% |
| MNKD | MannKind Corporation | $1.64B | $5.35 | 0.56% |
| ZBIO | Zenas BioPharma, Inc. | $1.63B | $38.83 | 4.19% |
| HROW | Harrow Health, Inc. | $1.55B | $41.78 | 1.16% |
| UPB | Upstream Bio, Inc. | $1.55B | $28.60 | 2.14% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $1.51B | $7.18 | 1.13% |
| COLL | Collegium Pharmaceutical, Inc. | $1.48B | $46.68 | 0.97% |
| CERT | Certara, Inc. | $1.47B | $9.16 | 0.22% |
| INVA | Innoviva, Inc. | $1.40B | $21.73 | 0.09% |
| ARDX | Ardelyx, Inc. | $1.39B | $5.80 | 2.19% |
| RLAY | Relay Therapeutics, Inc. | $1.37B | $7.92 | 1.37% |
| NRIX | Nurix Therapeutics, Inc. | $1.36B | $17.68 | 2.79% |
| URGN | UroGen Pharma Ltd. | $1.35B | $28.81 | 2.07% |
| DVAX | Dynavax Technologies Corporation | $1.34B | $11.37 | 0.52% |
| NKTR | Nektar Therapeutics | $1.33B | $65.21 | 0.73% |
| SEPN | Septerna, Inc. | $1.30B | $29.02 | 1.86% |
| SDGR | Schrödinger, Inc. | $1.29B | $17.56 | 0.80% |
| ELVN | Enliven Therapeutics, Inc. | $1.28B | $21.60 | 0.51% |
| SVRA | Savara Inc. | $1.28B | $6.28 | 17.07% |
| BLFS | BioLife Solutions, Inc. | $1.28B | $26.50 | 0.67% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.27B | $27.70 | 1.24% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $1.25B | $14.98 | 0.13% |
| TSHA | Taysha Gene Therapies, Inc. | $1.24B | $4.74 | 2.47% |
| XNCR | Xencor, Inc. | $1.24B | $17.32 | 0.35% |
| TRML | Tourmaline Bio, Inc. | $1.23B | $47.98 | 0.00% |
| INBX | Inhibrx Biosciences, Inc. | $1.22B | $84.12 | 0.55% |
| KOD | Kodiak Sciences Inc. | $1.22B | $22.98 | 2.41% |
| TNGX | Tango Therapeutics, Inc. | $1.21B | $10.93 | 1.53% |
| TYRA | Tyra Biosciences, Inc. | $1.20B | $22.56 | 2.41% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.19B | $7.18 | 0.00% |
| MBX | MBX Biosciences, Inc. Common Stock | $1.16B | $34.49 | 1.98% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.16B | $11.88 | 0.51% |
| ANAB | AnaptysBio, Inc. | $1.15B | $41.65 | 1.21% |
| PGEN | Precigen, Inc. | $1.15B | $3.83 | 2.41% |
| FTRE | Fortrea Holdings Inc. | $1.15B | $12.71 | 0.63% |
| NVAX | Novavax, Inc. | $1.15B | $7.05 | 1.44% |
| SANA | Sana Biotechnology, Inc. | $1.14B | $4.30 | 6.97% |
| USPH | U.S. Physical Therapy, Inc. | $1.12B | $73.85 | 0.12% |
| PHAT | Phathom Pharmaceuticals, Inc. | $1.11B | $15.62 | 2.97% |
| ATNF | 180 Life Sciences Corp. | $1.08B | $7.04 | 7.49% |
| PCRX | Pacira BioSciences, Inc. | $1.07B | $23.57 | 1.01% |
| BHVN | Biohaven Ltd. | $1.06B | $10.03 | 5.80% |
| KURA | Kura Oncology, Inc. | $1.06B | $12.14 | 1.25% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.05B | $16.17 | 1.13% |
| OPK | OPKO Health, Inc. | $1.04B | $1.35 | 1.12% |
| MDXG | MiMedx Group, Inc. | $1.02B | $6.88 | 0.00% |
| EYPT | EyePoint Pharmaceuticals, Inc. | $1.02B | $14.83 | 0.27% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $1.02B | $18.56 | 2.32% |
| GLYC | GlycoMimetics, Inc. | $1.01B | $15.71 | 2.76% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $999.16M | $3.62 | 0.55% |
| VERV | Verve Therapeutics, Inc. | $994.04M | $11.13 | 0.27% |
| DAWN | Day One Biopharmaceuticals, Inc. | $974.39M | $9.49 | 0.85% |
| MNMD | Mind Medicine (MindMed) Inc. | $955.75M | $12.65 | 4.55% |
| GDRX | GoodRx Holdings, Inc. | $953.62M | $2.81 | 0.71% |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $946.95M | $22.94 | 0.48% |
| NTLA | Intellia Therapeutics, Inc. | $942.03M | $8.99 | 5.52% |
| SPRY | ARS Pharmaceuticals, Inc. | $936.76M | $9.54 | 0.31% |
| ARVN | Arvinas, Inc. | $913.15M | $12.57 | 1.21% |
| RZLT | Rezolute, Inc. | $901.31M | $9.72 | 1.67% |
| RIGL | Rigel Pharmaceuticals, Inc. | $901.05M | $50.49 | 0.92% |
| ERAS | Erasca, Inc. | $899.37M | $3.17 | 1.28% |
| VIR | Vir Biotechnology, Inc. | $892.41M | $6.42 | 0.39% |
| LENZ | LENZ Therapeutics, Inc. | $851.83M | $30.52 | 0.65% |
| ABUS | Arbutus Biopharma Corporation | $845.61M | $4.40 | 0.23% |
| IOVA | Iovance Biotherapeutics, Inc. | $819.27M | $2.47 | 1.23% |
| ALMS | Alumis Inc. Common Stock | $800.76M | $7.67 | 0.39% |
| CMPX | Compass Therapeutics, Inc. | $800.68M | $5.79 | 7.42% |
| ESPR | Esperion Therapeutics, Inc. | $792.10M | $4.01 | 1.52% |
| REPL | Replimune Group, Inc. | $784.40M | $10.00 | 0.60% |
| CRMD | CorMedix Inc. | $772.92M | $9.81 | 1.66% |
| GOSS | Gossamer Bio, Inc. | $758.40M | $3.34 | 0.00% |
| GERN | Geron Corporation | $753.26M | $1.18 | 0.84% |
| EMBC | Embecta Corp. | $746.30M | $12.76 | 1.47% |
| KALV | KalVista Pharmaceuticals, Inc. | $731.40M | $14.47 | 2.62% |